July 2018 FDA Recall Testosterone Cypionate by Sun Pharmaceutical Industries, Inc.
D-0977-2018 - Presence of Particulate Matter

This Class II drug recall was voluntarily initiated by Sun Pharmaceutical Industries, Inc. on July 12, 2018 for the product Testosterone Cypionate. The FDA reported the reason for recall as presence of particulate matter. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0977-2018

Reason for Recall
Presence of Particulate Matter: organic and inorganic compounds detected in vials of product.
Initiated
07-12-2018
Reported
08-01-2018
Quantity
5215 units

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Sun Pharmaceutical Industries, Inc.
Nationwide within the United States
Testosterone Cypionate Injection, USP, 200 mg/mL, Rx only, 10 mL vials, Distributed by: Sun Pharmaceutical Industries, Inc., Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Industries, Ltd., Halol-Baroda Highway, Halol-389 350, Gujarat, India, NDC 62756-016-40

Batch or Lot Expiration Information

Lot# : JKS0280A, Exp. 06/2019